Research output: Contribution to journal › Article › peer-review
Analysis of in vitro cytotoxicity of human nk cell line co-expressing a psma-specific car and an antitumor agent lactaptin. / Belovezhets, T. N.; Matvienko, D. A.; Volkova, O. Y. et al.
In: Genes and Cells, Vol. 13, No. 3, 01.01.2018, p. 89-93.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Analysis of in vitro cytotoxicity of human nk cell line co-expressing a psma-specific car and an antitumor agent lactaptin
AU - Belovezhets, T. N.
AU - Matvienko, D. A.
AU - Volkova, O. Y.
AU - Koval, O. A.
AU - Tkachenko, A. V.
AU - Kuligina, E. V.
AU - Taranin, A. V.
AU - Richter, V. A.
N1 - Беловежец Т.Н., Матвиенко Д., Волкова О.Ю., Коваль О.А., Ткаченко А.В., Кулигина Е.В., Таранин А.В., Рихтер В. Создание и анализ цитотоксической активности in vitro NK-клеточной линии человека с экспрессией PSMA-специфичного химерного антигенного рецептора и противоопухолевого агента лактаптина // Гены и Клетки. - 2018. - Т. 13. - № 3. - С. 89-93
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Development of efficient antitumor modalities remains a priority of modern translation medicine. Adoptive transfer of autologous T cells expressing chimeric antigen receptors (CARs) specific for tumor-associated surface targets of B cells has demonstrated encouraging results in recent clinical trials. It is tempting therefore to adapt this approach to solid cancers and move it to universal/allogeneic formats. For this reason, it appears very attractive to use human NK cell lines as CAR carriers. Using lentiviral delivery, human NK cell line YT was modified to express a PSMA-specific CAR and to produce an anticancer peptide lactaptin. “Armored” CAR-YT-Lact cell line obtained shows cytotoxicity against PSMA-positive prostate adenocarcinoma cells. Accordingly, YT-Lact cells display a moderate and non-specific activity against PSMA-negative target cells, which may translate into a tighter control of tumor cell escape via antigen loss.
AB - Development of efficient antitumor modalities remains a priority of modern translation medicine. Adoptive transfer of autologous T cells expressing chimeric antigen receptors (CARs) specific for tumor-associated surface targets of B cells has demonstrated encouraging results in recent clinical trials. It is tempting therefore to adapt this approach to solid cancers and move it to universal/allogeneic formats. For this reason, it appears very attractive to use human NK cell lines as CAR carriers. Using lentiviral delivery, human NK cell line YT was modified to express a PSMA-specific CAR and to produce an anticancer peptide lactaptin. “Armored” CAR-YT-Lact cell line obtained shows cytotoxicity against PSMA-positive prostate adenocarcinoma cells. Accordingly, YT-Lact cells display a moderate and non-specific activity against PSMA-negative target cells, which may translate into a tighter control of tumor cell escape via antigen loss.
KW - CAR
KW - Lactaptin
KW - NK cell lines
KW - YT
UR - http://www.scopus.com/inward/record.url?scp=85085747080&partnerID=8YFLogxK
UR - https://www.elibrary.ru/item.asp?id=36965272
U2 - 10.23868/201811039
DO - 10.23868/201811039
M3 - Article
AN - SCOPUS:85085747080
VL - 13
SP - 89
EP - 93
JO - Genes and Cells
JF - Genes and Cells
SN - 2313-1829
IS - 3
ER -
ID: 24516553